Overview

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Status:
Completed
Trial end date:
2021-08-18
Target enrollment:
Participant gender:
Summary
This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaque psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer